Buy Like Buffett
Watchlist

Flagship explainer

How ClearPoint Neuro, Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$37M · 100%Cost of revenue$14.3M · 39%Gross profit$22.7M · 61%Operating income−$24.2M · −65%Income before tax−$25.5M · −69%Income tax$55000 · 0%Net income−$25.5M · −69%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$37M100%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-111231 · filed Mar 17, 2026
Cost of revenue$14.3M39%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-111231 · filed Mar 17, 2026
$22.7M61%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-111231 · filed Mar 17, 2026
−$24.2M−65%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-111231 · filed Mar 17, 2026
Income before tax−$25.5M−69%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-111231 · filed Mar 17, 2026
Income tax$550000%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-111231 · filed Mar 17, 2026
−$25.5M−69%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-111231 · filed Mar 17, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-111231 · filed Mar 17, 2026
· event Dec 31, 2025 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full ClearPoint Neuro, Inc. analysis at Buy Like Buffett